Live·Open questions in longevity research
Hypothesis Universe
Omega Point · Hypothesis

may sustain a cycle of damage between the gut and blood vessels

In linked gut and , may cause and repeated cell death. Damage that persists during confirmed but stops when or is suppressed would reject this mechanism.

Stage of verification

  1. Hypothesis published2026-09-30
  2. Indirect evidenceAssessed at 4 of 10
  3. Direct testAwaited

Map of the hypothesis

Hover over an icon or tap it to see its name.

Where in the body

Main connectionWhole body

Ageing mechanism

Main connectionGenomic instability

Direction

Kind of knowledge gap

No current scientific result answers this requirement.Void gap

A double ring marks the main placement where a group contains several values.

Lens
Regenerative replication damage
Goal
Затухание взаимного усиления возрастных повреждений
Competing hypotheses
3
Published
2026-09-30
As a hypothesis
8 / 10Clarity of mechanism
6 / 10Few extra conditions
10 / 10Completeness of the answer
6 / 10Novelty of the idea
10 / 10Few new entities
8 / 10Decisive experiment
8 / 10Silver-bullet potential
4 / 10Support from research
Poster: Cell division sustains gut–vascular damage
PosterOpen the sheet full size2026-09-30

Target map

Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.

  1. Rhythm or programme

    Cell

    The production of new cells through cell division

    Where this hypothesis actsInitially intact in the receiving tissue of a linked intestinal and model

    Hypotheses on this target 2
    Cell proliferationInhibition. Hypotheses on this target 11Activation. Hypotheses on this target 0Function preservation. Hypotheses on this target 0Feedback restoration. Hypotheses on this target 0Rhythm restoration. Hypotheses on this target 0Direct measurement. Hypotheses on this target 0
    • Inhibition1
    • Activation
    • Function preservation
    • Feedback restoration
    • Rhythm restoration
    • Direct measurement

    What is proposed

    Inhibition

    Temporarily halt cell division for one repair cycle

    With whatNot stated in the record

    HowReversibly control entry into division using two independent approaches restricted to , while monitoring epithelial viability and renewal

    Possible result

    Expected lasting cessation of damage waves in both tissues, stable and faster recovery of intestinal selectivity

    From the recordОбратимая остановка клеточного цикла только в строме принимающего звена на один цикл восстановления прекращает последующие волны в обеих тканях.

All targets of the lab

Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.

MoleculesAntibodies. Hypotheses on this target 3AntibodiesInterleukin-1α. Hypotheses on this target 3Interleukin-1αAmyloid seeds. Hypotheses on this target 2Amyloid seedsATP. Hypotheses on this target 2ATPCGRP. Hypotheses on this target 2CGRPHyaluronan. Hypotheses on this target 2HyaluronanInterleukin-1 receptor antagonist. Hypotheses on this target 2Interleukin-1 receptor antagonistInterleukin-6. Hypotheses on this target 2Interleukin-6Potassium. Hypotheses on this target 2PotassiumSpecialized pro-resolving lipid mediators. Hypotheses on this target 2Specialized pro-resolving lipid mediatorsAmmonia. Hypotheses on this target 1AmmoniaAntimicrobial peptides. Hypotheses on this target 1Antimicrobial peptidesBlood carbon dioxide. Hypotheses on this target 1Blood carbon dioxideBMP. Hypotheses on this target 1BMPCholesterol crystals. Hypotheses on this target 1Cholesterol crystalsCorticosterone. Hypotheses on this target 1CorticosteroneCryptic collagen ligands. Hypotheses on this target 1Cryptic collagen ligandsDKK1. Hypotheses on this target 1DKK1Double-stranded RNA. Hypotheses on this target 1Double-stranded RNAExtracellular electrolytes. Hypotheses on this target 1Extracellular electrolytesExtracellular histones. Hypotheses on this target 1Extracellular histonesFas ligand. Hypotheses on this target 1Fas ligandGlutamine. Hypotheses on this target 1GlutamineGlutathione. Hypotheses on this target 1GlutathioneHeavy chain–hyaluronan complexes. Hypotheses on this target 1Heavy chain–hyaluronan complexesHistamine. Hypotheses on this target 1HistamineInterleukin-10. Hypotheses on this target 1Interleukin-10Interleukin-22. Hypotheses on this target 1Interleukin-22Lipid A. Hypotheses on this target 1Lipid ALipid hydroperoxides. Hypotheses on this target 1Lipid hydroperoxidesM3 receptor autoantibodies. Hypotheses on this target 1M3 receptor autoantibodiesNAD+. Hypotheses on this target 1NAD+NKG2D ligands. Hypotheses on this target 1NKG2D ligandsNoggin. Hypotheses on this target 1NogginOxygen. Hypotheses on this target 1OxygenPeroxide. Hypotheses on this target 1PeroxidePGP-family peptides. Hypotheses on this target 1PGP-family peptidesPhenol-soluble modulins alpha (PSMα). Hypotheses on this target 1Phenol-soluble modulins alpha (PSMα)Phosphatidylserine. Hypotheses on this target 1PhosphatidylserinePlatelet-activating anti-PF4 immunoglobulin. Hypotheses on this target 1Platelet-activating anti-PF4 immunoglobulinProstaglandin E2. Hypotheses on this target 1Prostaglandin E2RNA–DNA hybrids. Hypotheses on this target 1RNA–DNA hybridsSenescent-cell secretions. Hypotheses on this target 1Senescent-cell secretionsSmall RNAs. Hypotheses on this target 1Small RNAsSoluble BCMA. Hypotheses on this target 1Soluble BCMAStratum corneum lipids. Hypotheses on this target 1Stratum corneum lipidsTacrolimus. Hypotheses on this target 1TacrolimusTGF-β1. Hypotheses on this target 1TGF-β1Tissue-binding antibodies. Hypotheses on this target 1Tissue-binding antibodiesTryptophan. Hypotheses on this target 1TryptophanTumstatin. Hypotheses on this target 1TumstatinVIP. Hypotheses on this target 1VIPWNT. Hypotheses on this target 1WNT
GenesRetroelements. Hypotheses on this target 3RetroelementsAcquired nuclear DNA. Hypotheses on this target 1Acquired nuclear DNAAntimicrobial protein coding sequences. Hypotheses on this target 1Antimicrobial protein coding sequencesExtrachromosomal DNA. Hypotheses on this target 1Extrachromosomal DNAHerpes simplex virus genomes. Hypotheses on this target 1Herpes simplex virus genomesHLA-II expression. Hypotheses on this target 1HLA-II expressionHormone-response regulatory variant combinations. Hypotheses on this target 1Hormone-response regulatory variant combinationsIFT88. Hypotheses on this target 1IFT88IRF4 half-site CpG methylation at the TGFB1 enhancer. Hypotheses on this target 1IRF4 half-site CpG methylation at the TGFB1 enhancerUV photolesions. Hypotheses on this target 1UV photolesions
Enzymes and receptorsProteases. Hypotheses on this target 7ProteasesEP2 receptor. Hypotheses on this target 5EP2 receptorGLS1. Hypotheses on this target 5GLS1YAP. Hypotheses on this target 5YAPmTOR. Hypotheses on this target 4mTORERK. Hypotheses on this target 3ERKFAK. Hypotheses on this target 2FAKGlutamine synthetase. Hypotheses on this target 2Glutamine synthetasemTORC1. Hypotheses on this target 2mTORC1Myosin. Hypotheses on this target 2MyosinNK1 receptor. Hypotheses on this target 2NK1 receptorp300. Hypotheses on this target 2p30012-lipoxygenase. Hypotheses on this target 112-lipoxygenaseAcid sphingomyelinase. Hypotheses on this target 1Acid sphingomyelinaseACOD1. Hypotheses on this target 1ACOD1Acyloxyacyl hydrolase. Hypotheses on this target 1Acyloxyacyl hydrolaseADAR1. Hypotheses on this target 1ADAR1AKT. Hypotheses on this target 1AKTAlpha-adrenergic receptors. Hypotheses on this target 1Alpha-adrenergic receptorsAMPK. Hypotheses on this target 1AMPKAntiproteases. Hypotheses on this target 1AntiproteasesApoptotic caspases. Hypotheses on this target 1Apoptotic caspasesβ-arrestin-2. Hypotheses on this target 1β-arrestin-2CAD. Hypotheses on this target 1CADCatalase. Hypotheses on this target 1CatalaseCathepsins. Hypotheses on this target 1CathepsinsCD1a. Hypotheses on this target 1CD1aCD40. Hypotheses on this target 1CD40CD45. Hypotheses on this target 1CD45CD47. Hypotheses on this target 1CD47Collagen IV. Hypotheses on this target 1Collagen IVCollagen VII. Hypotheses on this target 1Collagen VIIDermal collagen I and III triple helices. Hypotheses on this target 1Dermal collagen I and III triple helicesDNA polymerase theta. Hypotheses on this target 1DNA polymerase thetaEGFR. Hypotheses on this target 1EGFReIF2α. Hypotheses on this target 1eIF2αExecutioner caspases. Hypotheses on this target 1Executioner caspasesFactor XIII. Hypotheses on this target 1Factor XIIIFcγRIIa. Hypotheses on this target 1FcγRIIaFibrin. Hypotheses on this target 1FibrinFibronectin. Hypotheses on this target 1FibronectinFilamin C. Hypotheses on this target 1Filamin CFKBP12. Hypotheses on this target 1FKBP12FPR2/ALX receptor. Hypotheses on this target 1FPR2/ALX receptorβ-glucocerebrosidase. Hypotheses on this target 1β-glucocerebrosidaseGlucose-6-phosphate dehydrogenase. Hypotheses on this target 1Glucose-6-phosphate dehydrogenaseHCMV Fc-binding proteins. Hypotheses on this target 1HCMV Fc-binding proteinsHistones. Hypotheses on this target 1HistonesHsp70. Hypotheses on this target 1Hsp70HSPB1. Hypotheses on this target 1HSPB1Hyaluronan synthase 2. Hypotheses on this target 1Hyaluronan synthase 2Interleukin-10 receptor. Hypotheses on this target 1Interleukin-10 receptorIntestinal alkaline phosphatase. Hypotheses on this target 1Intestinal alkaline phosphataseKCC2. Hypotheses on this target 1KCC2LOX. Hypotheses on this target 1LOXM3 muscarinic receptor. Hypotheses on this target 1M3 muscarinic receptorMast-cell chymase. Hypotheses on this target 1Mast-cell chymaseMetabolic enzymes. Hypotheses on this target 1Metabolic enzymesMYC. Hypotheses on this target 1MYCMyeloperoxidase. Hypotheses on this target 1MyeloperoxidaseN-homocysteinylated circulating fibrinogen. Hypotheses on this target 1N-homocysteinylated circulating fibrinogenNeutrophil elastase. Hypotheses on this target 1Neutrophil elastaseNitric oxide synthase. Hypotheses on this target 1Nitric oxide synthaseNK3 receptor. Hypotheses on this target 1NK3 receptorNKG2D receptor. Hypotheses on this target 1NKG2D receptorNOTUM. Hypotheses on this target 1NOTUMORF2. Hypotheses on this target 1ORF2PAR1. Hypotheses on this target 1PAR1PCMT1. Hypotheses on this target 1PCMT1PD-1. Hypotheses on this target 1PD-1PD-L1. Hypotheses on this target 1PD-L1Peptide–MHC complexes. Hypotheses on this target 1Peptide–MHC complexesPhosphofructokinase. Hypotheses on this target 1PhosphofructokinasePIEZO1. Hypotheses on this target 1PIEZO1Prostaglandin E2 receptors. Hypotheses on this target 1Prostaglandin E2 receptorsRibosomes. Hypotheses on this target 1RibosomesRNase H1. Hypotheses on this target 1RNase H1SIRT6. Hypotheses on this target 1SIRT6TIM-4. Hypotheses on this target 1TIM-4TLR2. Hypotheses on this target 1TLR2TRPV4. Hypotheses on this target 1TRPV4TSG-6. Hypotheses on this target 1TSG-6V8 protease. Hypotheses on this target 1V8 proteaseZAKα. Hypotheses on this target 1ZAKα
CellsSenescent fibroblasts. Hypotheses on this target 7Senescent fibroblastsSenescent cells. Hypotheses on this target 4Senescent cellsOvarian somatic cells. Hypotheses on this target 3Ovarian somatic cellsT cells. Hypotheses on this target 3T cellsCooperating dangerous cells in breast tissue. Hypotheses on this target 2Cooperating dangerous cells in breast tissueMacrophages. Hypotheses on this target 2MacrophagesSenescent stromal cells. Hypotheses on this target 2Senescent stromal cellsAdrenal zona fasciculata cells. Hypotheses on this target 1Adrenal zona fasciculata cellsAntigen-presenting cells. Hypotheses on this target 1Antigen-presenting cellsAPC-altered cells. Hypotheses on this target 1APC-altered cellsBasal cells. Hypotheses on this target 1Basal cellsCapillary mural cells. Hypotheses on this target 1Capillary mural cellsCD1a-reactive T cells. Hypotheses on this target 1CD1a-reactive T cellsCompeting cells. Hypotheses on this target 1Competing cellsCorticotrophs. Hypotheses on this target 1CorticotrophsDendritic cells. Hypotheses on this target 1Dendritic cellsDifferentiated cells. Hypotheses on this target 1Differentiated cellsDll1-positive secretory progenitors. Hypotheses on this target 1Dll1-positive secretory progenitorsEpithelial progenitor cells. Hypotheses on this target 1Epithelial progenitor cellsFibroadipogenic progenitor cells. Hypotheses on this target 1Fibroadipogenic progenitor cellsFibroblasts. Hypotheses on this target 1FibroblastsGroup 3 innate lymphoid cells. Hypotheses on this target 1Group 3 innate lymphoid cellsHepatocytes. Hypotheses on this target 1HepatocytesIntestinal epithelial cells. Hypotheses on this target 1Intestinal epithelial cellsLgr5-positive stem cells. Hypotheses on this target 1Lgr5-positive stem cellsMast cells. Hypotheses on this target 1Mast cellsMature absorptive epithelial cells. Hypotheses on this target 1Mature absorptive epithelial cellsMedullary thymic epithelial cells. Hypotheses on this target 1Medullary thymic epithelial cellsMesenchymal stromal cells. Hypotheses on this target 1Mesenchymal stromal cellsMyeloid-biased long-term hematopoietic stem cells. Hypotheses on this target 1Myeloid-biased long-term hematopoietic stem cellsMyeloid–tissue hybrid cells. Hypotheses on this target 1Myeloid–tissue hybrid cellsMyofibroblasts. Hypotheses on this target 1MyofibroblastsNeutrophils. Hypotheses on this target 1NeutrophilsNK cells. Hypotheses on this target 1NK cellsReparative cells. Hypotheses on this target 1Reparative cellsSenescent osteogenic cells. Hypotheses on this target 1Senescent osteogenic cellsStromal cells. Hypotheses on this target 1Stromal cellsThymic epithelial cells. Hypotheses on this target 1Thymic epithelial cellsTumor-reactive T cells. Hypotheses on this target 1Tumor-reactive T cells
Tissues and matrixExtracellular matrix. Hypotheses on this target 11Extracellular matrixCollagen fibers. Hypotheses on this target 6Collagen fibersSkin tissue. Hypotheses on this target 4Skin tissueElastin–fibrillin network. Hypotheses on this target 3Elastin–fibrillin networkSubcutaneous adipose tissue. Hypotheses on this target 2Subcutaneous adipose tissueAntigen deposits. Hypotheses on this target 1Antigen depositsArterial resistance. Hypotheses on this target 1Arterial resistanceBasement membranes. Hypotheses on this target 1Basement membranesCell neighborhood geometry. Hypotheses on this target 1Cell neighborhood geometryCell surface geometry. Hypotheses on this target 1Cell surface geometryCorneocyte intercellular contacts. Hypotheses on this target 1Corneocyte intercellular contactsEpidermal mechanical stress. Hypotheses on this target 1Epidermal mechanical stressHyaluronan-proteoglycan matrix. Hypotheses on this target 1Hyaluronan-proteoglycan matrixMechanical prestress. Hypotheses on this target 1Mechanical prestressMotor units. Hypotheses on this target 1Motor unitsSensory axons. Hypotheses on this target 1Sensory axonsStratum corneum. Hypotheses on this target 1Stratum corneumStromal contacts. Hypotheses on this target 1Stromal contactsTendon tissue. Hypotheses on this target 1Tendon tissueTissue compression. Hypotheses on this target 1Tissue compressionTissue hydrostatic pressure. Hypotheses on this target 1Tissue hydrostatic pressureTissue mechanical relaxation spectrum. Hypotheses on this target 1Tissue mechanical relaxation spectrumVenous capacitance. Hypotheses on this target 1Venous capacitanceWet contact network between skin, clothing and bedding. Hypotheses on this target 1Wet contact network between skin, clothing and bedding
ProcessesEfferocytosis. Hypotheses on this target 8EfferocytosisSensory afferent activity. Hypotheses on this target 7Sensory afferent activityEpithelial barrier repair. Hypotheses on this target 6Epithelial barrier repairLipid peroxidation. Hypotheses on this target 6Lipid peroxidationProtein translation. Hypotheses on this target 6Protein translationCalcium phosphate mineral growth. Hypotheses on this target 4Calcium phosphate mineral growthInflammation resolution. Hypotheses on this target 4Inflammation resolutionInflammatory response. Hypotheses on this target 4Inflammatory responseVasomotor discharges. Hypotheses on this target 4Vasomotor dischargesActomyosin contraction. Hypotheses on this target 3Actomyosin contractionAntigen-receptor signaling. Hypotheses on this target 3Antigen-receptor signalingAntimicrobial immune functions. Hypotheses on this target 3Antimicrobial immune functionsCircadian phase distribution. Hypotheses on this target 3Circadian phase distributionMemory replay. Hypotheses on this target 3Memory replayMitophagy. Hypotheses on this target 3MitophagyScope inference. Hypotheses on this target 3Scope inferenceSleep continuity. Hypotheses on this target 3Sleep continuityThermal balance. Hypotheses on this target 3Thermal balanceTissue renewal timing. Hypotheses on this target 3Tissue renewal timingAntigen presentation. Hypotheses on this target 2Antigen presentationAntimicrobial memory. Hypotheses on this target 2Antimicrobial memoryAutophagy. Hypotheses on this target 2AutophagyBacteriophage replication. Hypotheses on this target 2Bacteriophage replicationBlood flow–sweat secretion synchrony. Hypotheses on this target 2Blood flow–sweat secretion synchronyBone remodeling. Hypotheses on this target 2Bone remodelingCell fusion. Hypotheses on this target 2Cell fusionCell recruitment. Hypotheses on this target 2Cell recruitmentEndocrine fluctuations. Hypotheses on this target 2Endocrine fluctuationsFerroptosis. Hypotheses on this target 2FerroptosisGap junction communication. Hypotheses on this target 2Gap junction communicationOxidative capacity. Hypotheses on this target 2Oxidative capacityPolyploidization. Hypotheses on this target 2PolyploidizationPositional signaling. Hypotheses on this target 2Positional signalingTransepithelial water transport. Hypotheses on this target 2Transepithelial water transportAct-to-training handoff. Hypotheses on this target 1Act-to-training handoffActivator–inhibitor signaling. Hypotheses on this target 1Activator–inhibitor signalingAnabolism. Hypotheses on this target 1AnabolismAntibody–effector co-occupancy. Hypotheses on this target 1Antibody–effector co-occupancyAntigen cross-presentation. Hypotheses on this target 1Antigen cross-presentationAntigen processing. Hypotheses on this target 1Antigen processingAntimicrobial deployment–epithelial repair synchrony. Hypotheses on this target 1Antimicrobial deployment–epithelial repair synchronyAttention allocation. Hypotheses on this target 1Attention allocationAutomatic recommendation delivery. Hypotheses on this target 1Automatic recommendation deliveryAutonomic recovery. Hypotheses on this target 1Autonomic recoveryBacterial utilization of exogenous fatty acids. Hypotheses on this target 1Bacterial utilization of exogenous fatty acidsCalcium homeostasis. Hypotheses on this target 1Calcium homeostasisCalcium signal decoding. Hypotheses on this target 1Calcium signal decodingCandidate/source binding. Hypotheses on this target 1Candidate/source bindingCardiovagal baroreflex. Hypotheses on this target 1Cardiovagal baroreflexCargo-mediated pathogen transfer. Hypotheses on this target 1Cargo-mediated pathogen transferCathelicidin carbamylation. Hypotheses on this target 1Cathelicidin carbamylationCausal test-selection policy. Hypotheses on this target 1Causal test-selection policyCell competition. Hypotheses on this target 1Cell competitionCell-cycle entry. Hypotheses on this target 1Cell-cycle entryCell membrane repair. Hypotheses on this target 1Cell membrane repairCell survival signaling. Hypotheses on this target 1Cell survival signalingCellular–antibody response timing. Hypotheses on this target 1Cellular–antibody response timingCentrosome organization. Hypotheses on this target 1Centrosome organizationcGAS–STING signaling. Hypotheses on this target 1cGAS–STING signalingChromatin programme of chronic secretion. Hypotheses on this target 1Chromatin programme of chronic secretionCoagulation cascade. Hypotheses on this target 1Coagulation cascadeCollagen crosslinking. Hypotheses on this target 1Collagen crosslinkingColonocyte metabolism. Hypotheses on this target 1Colonocyte metabolismCommunicative planning. Hypotheses on this target 1Communicative planningCommunity-conditioned modification of reconstruction. Hypotheses on this target 1Community-conditioned modification of reconstructionCompeting action accessibility. Hypotheses on this target 1Competing action accessibilityCompetitive drug displacement. Hypotheses on this target 1Competitive drug displacementComplement cascade. Hypotheses on this target 1Complement cascadeConcurrent incompatible-update reconciliation. Hypotheses on this target 1Concurrent incompatible-update reconciliationConvention compatibility. Hypotheses on this target 1Convention compatibilityCue-to-intention binding. Hypotheses on this target 1Cue-to-intention bindingCulture-to-risk feedback. Hypotheses on this target 1Culture-to-risk feedbackCutaneous vasodilation. Hypotheses on this target 1Cutaneous vasodilationDefault-preserving meta-choice. Hypotheses on this target 1Default-preserving meta-choiceDNA integration. Hypotheses on this target 1DNA integrationDNA repair. Hypotheses on this target 1DNA repairDNA replication licensing. Hypotheses on this target 1DNA replication licensingEnactment-cost feedback. Hypotheses on this target 1Enactment-cost feedbackEndocrine–circadian phase relationship. Hypotheses on this target 1Endocrine–circadian phase relationshipEndothelium-dependent vasodilation. Hypotheses on this target 1Endothelium-dependent vasodilationEntity correspondence. Hypotheses on this target 1Entity correspondenceEpidermal sealing–dermal remodeling synchrony. Hypotheses on this target 1Epidermal sealing–dermal remodeling synchronyEpidermal turnover. Hypotheses on this target 1Epidermal turnoverER-selective autophagy. Hypotheses on this target 1ER-selective autophagyErythrocyte arrival timing. Hypotheses on this target 1Erythrocyte arrival timingExcitation–secretion coupling. Hypotheses on this target 1Excitation–secretion couplingExtracellular infectious particle stabilization. Hypotheses on this target 1Extracellular infectious particle stabilizationExtracellular vesicle clearance. Hypotheses on this target 1Extracellular vesicle clearanceFailure detection and handover. Hypotheses on this target 1Failure detection and handoverFibrinolysis. Hypotheses on this target 1FibrinolysisGlutamine–glutamate cycle. Hypotheses on this target 1Glutamine–glutamate cycleGYS1-NONO condensation. Hypotheses on this target 1GYS1-NONO condensationHexosamine biosynthesis. Hypotheses on this target 1Hexosamine biosynthesisHistone export. Hypotheses on this target 1Histone exportHorizontal nuclear DNA transfer. Hypotheses on this target 1Horizontal nuclear DNA transferHost oxidant production. Hypotheses on this target 1Host oxidant productionIgG Fc glycosylation. Hypotheses on this target 1IgG Fc glycosylationImmune surveillance. Hypotheses on this target 1Immune surveillanceImmune target discrimination. Hypotheses on this target 1Immune target discriminationInstruction-scope conversion. Hypotheses on this target 1Instruction-scope conversionInterpretation switching. Hypotheses on this target 1Interpretation switchingIntracellular protein clearance. Hypotheses on this target 1Intracellular protein clearanceKeratinocyte polarity. Hypotheses on this target 1Keratinocyte polarityLymphocyte–APC contact timing. Hypotheses on this target 1Lymphocyte–APC contact timingLysosomal membrane permeabilization. Hypotheses on this target 1Lysosomal membrane permeabilizationLysosomal peptidoglycan degradation. Hypotheses on this target 1Lysosomal peptidoglycan degradationLysosome reformation. Hypotheses on this target 1Lysosome reformationMacromolecular crowding. Hypotheses on this target 1Macromolecular crowdingMeal–activity timing. Hypotheses on this target 1Meal–activity timingMechanical interference among lymphocytes. Hypotheses on this target 1Mechanical interference among lymphocytesMechanical load–mitosis timing. Hypotheses on this target 1Mechanical load–mitosis timingMechanical loading. Hypotheses on this target 1Mechanical loadingMechanoradical production. Hypotheses on this target 1Mechanoradical productionMental accounting. Hypotheses on this target 1Mental accountingMicrobial chemical defense. Hypotheses on this target 1Microbial chemical defenseMitochondrial fusion. Hypotheses on this target 1Mitochondrial fusionMitochondrial maintenance. Hypotheses on this target 1Mitochondrial maintenanceMitochondrial proton leak. Hypotheses on this target 1Mitochondrial proton leakMitochondrial transfer. Hypotheses on this target 1Mitochondrial transferMitosis. Hypotheses on this target 1MitosisMitotic entry in basal keratinocytes. Hypotheses on this target 1Mitotic entry in basal keratinocytesMitotic synchrony. Hypotheses on this target 1Mitotic synchronyMnemonic retention demand. Hypotheses on this target 1Mnemonic retention demandMuscle fiber adaptation. Hypotheses on this target 1Muscle fiber adaptationMutagenesis. Hypotheses on this target 1MutagenesisNeurogenic vasodilation. Hypotheses on this target 1Neurogenic vasodilationNeurokinin signaling. Hypotheses on this target 1Neurokinin signalingNeuronal secretion. Hypotheses on this target 1Neuronal secretionNF-κB activation. Hypotheses on this target 1NF-κB activationNitrogen-processing reaction network. Hypotheses on this target 1Nitrogen-processing reaction networkOrganelle maintenance. Hypotheses on this target 1Organelle maintenanceOxidative metabolism. Hypotheses on this target 1Oxidative metabolismParacrine signal–response synchrony. Hypotheses on this target 1Paracrine signal–response synchronyPartner retention and sorting. Hypotheses on this target 1Partner retention and sortingPathogen export. Hypotheses on this target 1Pathogen exportPeptide conjugation. Hypotheses on this target 1Peptide conjugationPeroxide clearance. Hypotheses on this target 1Peroxide clearancePlatelet adhesion. Hypotheses on this target 1Platelet adhesionPost-injury illness cascades. Hypotheses on this target 1Post-injury illness cascadesPreference construction. Hypotheses on this target 1Preference constructionPrimary cilium assembly. Hypotheses on this target 1Primary cilium assemblyProspective time allocation. Hypotheses on this target 1Prospective time allocationProtein carbamylation. Hypotheses on this target 1Protein carbamylationPublic commitment to cultural propositions. Hypotheses on this target 1Public commitment to cultural propositionsReceptor signal integration. Hypotheses on this target 1Receptor signal integrationReciprocal phase resetting. Hypotheses on this target 1Reciprocal phase resettingRegeneration–immune recognition timing. Hypotheses on this target 1Regeneration–immune recognition timingRegulatory-cell cytotoxicity. Hypotheses on this target 1Regulatory-cell cytotoxicityRelational memory. Hypotheses on this target 1Relational memoryRenal tubular reabsorption. Hypotheses on this target 1Renal tubular reabsorptionRibosome assembly. Hypotheses on this target 1Ribosome assemblyRNA splicing. Hypotheses on this target 1RNA splicingScratch contact. Hypotheses on this target 1Scratch contactScratch motor program. Hypotheses on this target 1Scratch motor programSemantic rewriting. Hypotheses on this target 1Semantic rewritingSensory integration. Hypotheses on this target 1Sensory integrationSkin adhesion. Hypotheses on this target 1Skin adhesionSkin barrier repair. Hypotheses on this target 1Skin barrier repairSolar radiation absorption. Hypotheses on this target 1Solar radiation absorptionSource-conditioned reconstruction. Hypotheses on this target 1Source-conditioned reconstructionSpatial coordination of ERK signaling. Hypotheses on this target 1Spatial coordination of ERK signalingStromal cell–matrix mechanical coupling. Hypotheses on this target 1Stromal cell–matrix mechanical couplingSweat evaporation. Hypotheses on this target 1Sweat evaporationThermoregulatory feedback. Hypotheses on this target 1Thermoregulatory feedbackTissue growth. Hypotheses on this target 1Tissue growthTissue renewal cycles. Hypotheses on this target 1Tissue renewal cyclesTissue repair. Hypotheses on this target 1Tissue repairTranscription. Hypotheses on this target 1TranscriptionTranscription-factor partnerships. Hypotheses on this target 1Transcription-factor partnershipsTranscription–replication conflicts. Hypotheses on this target 1Transcription–replication conflictsTranscriptional priming in estrogen-responsive cells. Hypotheses on this target 1Transcriptional priming in estrogen-responsive cellsTranscriptional repression. Hypotheses on this target 1Transcriptional repressionTransdermal drug absorption. Hypotheses on this target 1Transdermal drug absorptionTransmission timing. Hypotheses on this target 1Transmission timingtRNA queuosine modification. Hypotheses on this target 1tRNA queuosine modificationUbiquitin-dependent proteasomal degradation. Hypotheses on this target 1Ubiquitin-dependent proteasomal degradationVariant competition and selection. Hypotheses on this target 1Variant competition and selectionVascular obstruction. Hypotheses on this target 1Vascular obstructionCell proliferation. Hypotheses on this target 2Cell proliferation
Microbial communitiesGut microbiota. Hypotheses on this target 3Gut microbiotaBacterial pathogens. Hypotheses on this target 1Bacterial pathogens
MeasurementsCultural transmission mechanism classification. Hypotheses on this target 9Cultural transmission mechanism classificationMenopause syndrome classification. Hypotheses on this target 5Menopause syndrome classificationSweat secretory response. Hypotheses on this target 5Sweat secretory responseCircadian phase. Hypotheses on this target 2Circadian phaseCognitive performance measurements. Hypotheses on this target 2Cognitive performance measurementsNyquist stability boundary. Hypotheses on this target 2Nyquist stability boundaryRecovery status classification. Hypotheses on this target 2Recovery status classificationAntibody neutralizing activity. Hypotheses on this target 1Antibody neutralizing activityApplied shear load. Hypotheses on this target 1Applied shear loadCausal-binding accessibility. Hypotheses on this target 1Causal-binding accessibilityClone size measurement. Hypotheses on this target 1Clone size measurementContractile exit assessment. Hypotheses on this target 1Contractile exit assessmentFunctional performance measurements. Hypotheses on this target 1Functional performance measurementsInvasion measurement. Hypotheses on this target 1Invasion measurementMitotically reactivatable infected cell count. Hypotheses on this target 1Mitotically reactivatable infected cell countmt-Keima signal. Hypotheses on this target 1mt-Keima signalOptical oxygen saturation estimate. Hypotheses on this target 1Optical oxygen saturation estimatePerfusion measurements. Hypotheses on this target 1Perfusion measurementsSemantic coding. Hypotheses on this target 1Semantic codingSkin ageing index. Hypotheses on this target 1Skin ageing indexSkin microdamage classification. Hypotheses on this target 1Skin microdamage classificationSkin redness. Hypotheses on this target 1Skin rednessSkin water evaporation measurement. Hypotheses on this target 1Skin water evaporation measurementTarget-specific immune response measurements. Hypotheses on this target 1Target-specific immune response measurementsTreatment response classification. Hypotheses on this target 1Treatment response classificationViable pathogen burden. Hypotheses on this target 1Viable pathogen burden

Solid and named: the targets of this hypothesis

Explore in depth

The logic

The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.

The descent, in plain words

The body’s attempt to replace damaged cells could keep an injury going after its original cause has disappeared. The unexpected move is to briefly stop otherwise intact cells from dividing, on the proposal that their attempts at repair generate the next wave of damage. This is a hypothesis generated by the pipeline, not a measured result.

The proposed mechanism, link by link
  1. A small initial injury causes , a regulated process of cell death.
  2. Dying cells are proposed to release , a signaling substance, which prompts initially intact supporting cells to divide for repair.
  3. in old tissue is proposed to cause , difficulty copying genetic material before division, and fresh damage.
  4. Newly damaged cells are proposed to die and trigger further .
  5. Unspecified products carried between the gut and blood vessels are proposed to spread this cycle between their supporting cells.
  6. Repair is proposed to switch from a response that ends after injury to a cycle that keeps generating damage after the initial cause is removed; the proposed boundary depends on how many newly damaged cells follow an episode of replacement division.
  7. A brief stop in division in one tissue is predicted to extinguish the cycle, allowing recovery to persist after division and exchange between tissues resume.
A picture for it

A repair crew patches a damaged floor, but its work cracks neighboring boards and creates the next repair job. Briefly stopping the work could end the repeating damage if ordinary activity afterward does not restart it.

Where the picture breaks: Cells are not workers, and stopping their division can also prevent necessary repair. The picture does not explain what travels between tissues or establish that a temporary pause would produce lasting recovery.

  1. Master questionstep 01 of 04

    A single treatment aimed at a shared cause of mutually reinforcing aging damage might benefit several body systems.

    Rests on: The goal is to find a shared causal link through which one intervention could interrupt several processes of aging.

    Assumption

    The goal assumes that a shared causal link can be identified and altered in a way that benefits several systems. The supplied material does not establish such a target.

  2. Goal pillarstep 02 of 04

    Weakening the ways age-related damage reinforces itself is the chosen route toward benefits across body systems.

    Rests on: The master question explicitly identifies mutual reinforcement between aging processes as a reason to seek a shared target.

    Stated in the chain
  3. Gap questionstep 03 of 04

    Damage passed between tissues might have a boundary below which it stops sustaining itself, allowing a brief intervention at one link to produce lasting recovery despite continuing daily burdens.

    Rests on: The preceding goal identifies mutual reinforcement as the target, but does not establish a boundary separating continuing damage from lasting recovery.

    Assumption

    The question introduces, for investigation, the possibility of a self-sustaining state that can be switched off through one link. Mutual reinforcement alone does not establish that such a boundary exists.

  4. Hypothesisstep 04 of 04

    of , the supporting cells around a tissue’s working cells, is proposed to generate fresh damage and sustain an exchange of damaging products between the gut and blood vessels. Briefly stopping division in one tissue is predicted to end the cycle.S2S3S5

    Rests on: The gap question supplies the search for an interruptible cycle. Partial biological precedent comes from Oncogene (2014), whose supplied abstract connects reduced cell death with reduced replacement division and copying-related damage in irradiated mice, and Genes & Development (2010), which reports a similar connection in blood-forming cells protected from radiation-induced death. Neither establishes an aging gut–blood-vessel cycle or its interruption by briefly stopping division. Molecular Cancer Research (2019) reports cell death, replacement division and genetic damage together in mouse liver lacking a particular gene, but does not establish the proposed sequence between tissues.

    Supported by literature

What is carried, and what is not. The screened literature speaks to two local links: cell death prompting replacement division, and replacement division being associated with damage from copying genetic material; the mouse liver source also reports these events together. These findings come from other experimental settings, and none establishes the proposed sequence end to end, its after the original injury, or lasting recovery after a temporary stop in division.

Where the reasoning is carried by something unstated · 2
  • Master question. The goal assumes that a shared causal link can be identified and altered in a way that benefits several systems. The supplied material does not establish such a target.
  • Gap question. The question introduces, for investigation, the possibility of a self-sustaining state that can be switched off through one link. Mutual reinforcement alone does not establish that such a boundary exists.
How a result here could mislead · 3
  • Less damage after stopping division could reflect loss of cells, reduced exchange between tissues, or interference with a rival mechanism rather than a requirement for division itself. The rivals invoke changing proportions of repair-contributing cells, spreading damage through chemically altered fats, or continuing production of mineral particles. What closes it: The specification already requires two independent ways to stop division and separate checks of cell survival and the , the cell layer controlling passage across the gut wall. Causal separation also requires checking that exchange remains functional and measuring whether the intervention changes cell , fat damage or production; those comparisons are not specified.
  • Damage concentrated in descendants of dividing cells could be read as evidence that division created it, even if those cells were already injured or especially exposed before dividing. What closes it: Tracking cells and their descendants must establish damage before and after entry into division, alongside initially comparable cells that do not divide. Tracking descendants alone does not establish when or why their damage began.
  • Recovery during the pause could be mistaken for a lasting reset. Conversely, the specification’s request to restore the effect by restarting division is ambiguous: spontaneous return of damage would conflict with its prediction that recovery survives resumed division. What closes it: The test must distinguish restarting division alone from restarting division together with a new damaging trigger. Follow-up after division and resume, the unchanged daily burden, and the criteria for lasting recovery must be fixed in advance. The supplied material gives no follow-up duration or definition of , its named outcome measure.

What would make this wrong. The central necessity claim would fail if new damage continued spreading between the tissues after the initial damaging stimulus was removed and division was demonstrably stopped in the targeted supporting cells for the proposed repair interval. The hypothesis explicitly identifies continued spread under those conditions, combined with its cessation when fat oxidation or formation is suppressed, as grounds for rejection in favor of the corresponding rival.

What it would change. If the hypothesis held, the search for one intervention benefiting several systems would gain a specific candidate: interrupting harmful long enough to stop damage passing between tissues. Success would have to mean recovery that persists after normal division resumes, rather than reduced damage only during treatment. Even that result in a linked tissue model would not establish longer life, benefits across an aging organism, or an effective intervention in humans.

Sources read · 5

4 literature searches, 2 full texts, 3 abstract-only; 5 source(s) assessed against this question using the available text. A bounded search is not evidence of absence.

S1Background

In vitro and in vivo evaluation of possible pro-survival activities of PGE2, EGF, TPO and FLT3L on human hematopoiesis. · Haematologica · 2019

“Prostaglandin E2 protects human hematopoietic stem cells short-term from apoptosis but has toxic long-term effects”

Does not settle: Источник не исследует кишечную или сосудистую строму, межтканевую петлю, выделение PGE2 апоптотическими клетками, компенсаторную пролиферацию после повреждения или её кратковременную остановку.

S2Partly answers itAbstract only

Deletion of Irf5 protects hematopoietic stem cells from DNA damage-induced apoptosis and suppresses γ-irradiation-induced thymic lymphomagenesis. · Oncogene · 2014

“Suppression was due, in part, to reduced thymocyte and HSC apoptosis, resulting in reduced compensatory proliferation, and reduced replication stress-associated DNA damage.”

Does not settle: This abstract reports an irradiation model in mice involving thymocytes and hematopoietic stem/progenitor cells. It does not establish a self-sustaining gut–vascular stromal loop, prostaglandin E2 signaling, circulating products, persistence after the initiating damage is removed, a threshold for damage per compensatory division, SPV_1 stabilization, or effects of transiently stopping division.

S3Partly answers itAbstract only

DNA Damage, Liver Injury, and Tumorigenesis: Consequences of DDX3X Loss. · Molecular cancer research : MCR · 2019

“Loss of Ddx3x led to profound ductular reactions, cell apoptosis, and compensatory proliferation in female mutants at 6 weeks of age. The sustained phosphorylation of histone H2AX (γH2AX) and significant accumulation of DNA single-strand breaks and double-strand breaks in liver indicated that the replicative stress occurred in female mutants.”

Does not settle: This abstract reports Ddx3x-deficient mouse liver findings. It does not establish a self-sustaining gut–vascular stromal loop, prostaglandin E2 release by apoptotic cells, circulating mediators, the proposed threshold, or whether temporarily stopping division reverses the cycle or stabilizes SPV_1.

S4BackgroundAbstract only

NF-κB-dependent DNA damage-signaling differentially regulates DNA double-strand break repair mechanisms in immature and mature human hematopoietic cells. · Leukemia · 2015

“To consider chemotherapy/radiation-induced compensatory proliferation, we established cycling HSPC cultures.”

Does not settle: It does not assess gut or vascular stroma, apoptosis-derived prostaglandin E2, replication stress caused by repair proliferation, an intertissue damage cycle, circulating products, or whether transiently stopping division extinguishes such a cycle.

S5Partly answers it

Apoptosis of leukocytes triggered by acute DNA damage promotes lymphoma formation. · Genes & development · 2010

“Puma −/− HSCs, protected from IR-induced cell death, show reduced compensatory proliferation and replication stress-associated DNA damage, and fail to form thymic lymphomas”

Does not settle: Открытыми остаются роль простагландина E2, стромальные клетки кишечника и сосудов, межтканевая циркулирующая петля, её самоподдержание после устранения исходного повреждения, порог повреждений и эффект краткой остановки деления.

The gap this hypothesis explains

Nothing is known here: the question has not been asked of this system.

Can breaking one link cross a damage threshold and restore aging tissues, beyond simply reducing daily harm?

Original wording · exactly as the pipeline generated it
The gap question, as the engine wrote it

Существует ли у стареющего организма , пересечение которого воздействием на одно звено вызывает устойчивое восстановление, и как размыкание петли отделит этот механизм от общей суточной нагрузки?

What this question is asking

The question asks whether damage passing between tissues can become self-sustaining, and whether interrupting one causal link can switch an aging organism back toward lasting recovery. It assumes that interacting processes form a complete feedback loop, in which damage eventually feeds back to reinforce its own cause; the supplied material does not establish that full loop. The proposed signs of recovery are shrinking repeated peaks of damage, restoration of a protective tissue barrier within the first day, and a delay between responses in different systems that stays within specified limits across successive daily cycles. The decisive distinction is whether recovery follows from stopping the loop from sustaining itself or simply from reducing the total harmful burden each day. The supplied material names linked-organ and timing measurements as available tools, but does not describe their validation, the relevant barrier, or the acceptable timing limits.

What the terms mean
Self-sustaining damage
Damage whose consequences generate enough further damage to keep the process operating. The question asks whether this happens between tissues, rather than merely whether injury persists while an external harmful exposure continues.
Feedback loop or positive feedback
A chain of effects that returns to influence its starting point; positive feedback reinforces the initial change. A connection from one tissue to another establishes only part of a loop unless a returning influence is also established.
Causal link
A connection in which changing one process changes a downstream process. The proposed intervention targets one such connection within the claimed damage loop.
Damage threshold or tipping point
A boundary between different patterns of behavior, here damage that fades and damage that maintains itself. The supplied question proposes such a boundary but gives no established value or measurement for it.
Daily harmful burden
The total harm imposed over a day, as invoked by the question. The supplied material does not specify its components or how they would be combined into a measurement.
Tissue barrier and gut barrier
A layer of cells that controls movement between compartments, such as between the gut’s contents and the rest of the body. Barrier function varies in degree; a leaky gut means impaired control, rather than necessarily a complete physical break.
Delay between system responses
The elapsed time between a change in one biological system and a corresponding change in another. The question treats stable timing over daily cycles as a recovery criterion but does not provide acceptable limits.
Linked-organ and timing measurements
Tools that the supplied gap description says can investigate connections between organ systems and the timing of their responses. Their construction, capabilities, and validation are not supplied.
Liver scarring
Accumulation of scar tissue in the liver, also called hepatic fibrosis. S2 describes interacting injury processes that promote it, which provides a narrower example of self-amplifying damage.
Inflammation
A biological response to injury or threat that can also contribute to damage when it persists or becomes excessive. The sources discuss it in several settings, which do not automatically establish the same mechanism.
Regulated cell death
Cell death carried out through an organized biological process. S3 concerns a threshold enabling such a process within cells, not a demonstrated recovery threshold between tissues.
Macrophages
Immune cells involved in responding to injury and clearing material. They are the cellular setting identified in the supplied summary of S3.
Atrial fibrillation
An irregular heart rhythm involving the heart’s upper chambers. Susceptibility to this rhythm is the outcome reported in S5, rather than a measurement of overall recovery from aging.
Signaling component
A molecule or biological process that helps transmit an effect within or between cells. S5 reports benefits from blocking particular components of the gut–heart connection.
Cellular senescence
A cell state commonly characterized by a lasting halt in division and changes in cell function. It is not synonymous with aging of an entire organism; S7 concerns this state in the intestine.
Polystyrene particles
Small pieces of a type of plastic. Their exposure, together with particular dietary conditions, defines the injury setting described in S7.
Microorganism communities
Groups of microscopic organisms living in a particular environment, including within or on the body. S6 discusses how aging-related changes in these communities connect with bodily dysfunction.
Coronavirus disease 2019
The infectious disease discussed in S8. Its reported progression provides a different disease context for barrier failure and multiple-organ dysfunction.
Lactylation
A chemical modification of proteins. S9 discusses its inhibition as a way of suppressing a reinforcing pathway associated with brain inflammation.
Microglia
Immune cells in the brain. Excessive activation of these cells is part of the inflammation mechanism described in S9.
Alzheimer’s disease model
A research system representing selected features of a disease that damages brain function. Findings in that model do not by themselves establish effects throughout an aging organism.
What the question takes for granted
Premise only partly supported
Interacting damage processes in an aging organism form a complete, self-amplifying loop between tissues that can be distinguished from the total daily harmful burden; linked-organ and timing measurements already provide tools for investigating it.

The assumption is that injury can pass between tissues and return to worsen the injury that started the sequence. A protective tissue barrier is one proposed part of this sequence, while the time between responses in different systems is a proposed measurement of their connection. If this assumption held, improvement after interrupting one connection could potentially be interpreted as a change in the cycle itself, rather than only as less harm entering the system.

The read sources support narrower elements: S2 describes a self-amplifying network in chronic liver injury, S5 reports that interventions affecting the gut–heart connection reduce susceptibility to an abnormal heart rhythm in mice, and S9 reports suppression of a reinforcing process within a brain-disease model. These do not establish a complete self-sustaining loop between tissues in an aging organism. S4 explicitly presents the threshold mechanism as a hypothesis. None of the supplied excerpts validates the named measurement tools or establishes a way to separate loop interruption from reduced daily harmful burden.S2S4S5S9

The same question asked without the part nothing read establishes:

  • Does interrupting one causal connection between tissues in an aging organism produce lasting recovery through a damage threshold, beyond the effect of reducing total daily harm?
  • Do connected tissues in an aging organism continue to reinforce one another’s damage after the initiating harmful burden subsides?
What turns on the answer
  • A threshold permits lasting recovery If interrupting one link reduces reinforcement below the level needed to sustain damage, each successive round of damage would weaken. Recovery across connected tissues would then reflect a change in the feedback process, provided that reduced daily harm alone does not explain it.
  • Improvement reflects reduced daily harm If the intervention reduces the harmful burden without changing a self-sustaining process, less damage could occur while that reduction continues. The improvement would not establish that a threshold was crossed or that recovery would persist when the burden returned.
  • One interrupted link does not restore the system If damage continues to sustain itself despite interruption of the chosen link, improvement in one tissue would not establish recovery across the connected tissues. That outcome would leave the proposed single-link route to lasting recovery unestablished, without by itself ruling out every possible damage threshold.
Why it matters

Under the proposed mechanism, damage in one tissue affects another, and a returning effect reinforces damage in the first tissue. If that reinforcement can maintain damage, reducing an initiating harmful exposure might leave the cycle operating. Interrupting an essential link could then allow damage to subside across the connected tissues, but lasting recovery is a further claim that needs its own evidence. Mistaking a temporary reduction in daily harm for this transition would turn a limited improvement into an unsupported claim that the organism had entered a durable recovery state.

What is already established

RL-1 и RL-2 позволяют исследовать связи, но полной петли не установлен.

What would have to be true

Повторные пики повреждения затухают; восстанавливается в первые сутки, остаётся в заданных пределах при последовательных суточных циклах.

What is missing

Отсутствует экспериментально установленный переход между затухающим и самоподдерживающимся повреждением, управляемый одним причинным звеном.

The mechanism it proposes

The engine's own statement of the hypothesis, in full.

После небольшого повреждения самоподдерживающуюся создаёт избыточное деление первоначально сохранных клеток . выделяют , который запускает . В старой ткани эта порождает и следующую волну . Возникает цикл «гибель клеток → → новое повреждение», связывающий кишечную и сосудистую через . Порог определяется числом новых повреждённых клеток, возникающих вследствие одного эпизода . Смелая часть гипотезы: продолжающееся деление сохранных клеток необходимо для поддержания всей петли, даже когда первоначальный источник повреждения уже устранён. Краткая обратимая в одном звене должна погасить цикл и стабилизировать , после чего восстановление ускорится.

Testing and possible results

The prediction that would tell it apart

A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.

В связанной модели кишечника и после удаления исходного повреждающего стимула новые очаги повреждения преимущественно возникают в потомках клеток, вступивших в деление после первичного эпизода. Обратимая только в на один цикл восстановления прекращает последующие волны в обеих тканях. Эффект сохраняется после возобновления деления и при прежней суточной нагрузке. Численность первоначальных при этом может оставаться прежней. Если повреждение продолжает распространяться при подтверждённой , а прекращается при подавлении или , гипотеза отвергается в пользу соответствующего соперника.

Would tell it apart from at least one rival. The prediction specifies observable damage distribution, cessation of damage waves after a defined intervention, persistence after division and exchange resume, and an explicit rejection condition. No rival prediction was supplied. Only a bench experiment would settle it.

What testing it would take

The engine's own read on whether this is testable with methods that already exist.

Проверка возможна в моделях с , и обратимым управлением . Воздействие ограничивают , отдельно контролируя и . Для нужны два независимых способа временно и восстановление эффекта после экспериментального возобновления .

Other explanations

Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.

This hypothesis predicts

В связанной модели кишечника и после удаления исходного повреждающего стимула новые очаги повреждения преимущественно возникают в потомках клеток, вступивших в деление после первичного эпизода. Обратимая только в на один цикл восстановления прекращает последующие волны в обеих тканях. Эффект сохраняется после возобновления деления и при прежней суточной нагрузке. Численность первоначальных при этом может оставаться прежней. Если повреждение продолжает распространяться при подтверждённой , а прекращается при подавлении или , гипотеза отвергается в пользу соответствующего соперника.

  • What would separate them

    Selection against repair-contributing stromal cells may sustain damage across tissues predicts: При одинаковых общей численности клеток, начальном повреждении и суточной нагрузке исходная доля определяет противоположные долгосрочные траектории. Ниже независимо оценённого порога эта доля уменьшается, выше него возрастает; вслед за этим соответственно усиливаются или затухают повторные повреждения. Краткое вмешательство даёт устойчивый результат только при пересечении . Одинаковое временное торможение деления обеих , сохраняющее их соотношение, устойчивого переключения не вызывает. При экспериментально постоянном предполагаемый переход исчезает, даже если продолжается.

  • What would separate them

    A lipid oxidation chain may sustain damage between gut and vascular tissue predicts: каждого тканевого звена показывает последовательное образование новых сначала в принимающей ткани, затем в исходной после возврата . Повреждающая активность регенерируется при , превышая остаточную активность первоначального материала с учётом его . Она сохраняется при и отсутствии , но прекращается после избирательного в возвращаемой . Размыкание петли на время исчезновения этой активности обеспечивает устойчивое восстановление после повторного соединения. Если эффект требует или переносится очищенной минеральной при удалённых , гипотеза отвергается.

  • What would separate them

    Calcium phosphate particle growth may sustain damage between the gut and blood vessels predicts: При одинаковых , , белковом составе и внешних нагрузках малая добавка охарактеризованных запускает длительное образование новых частиц и повторные пики повреждения. Частицы с подавленной способностью к росту при сопоставимых размере и такого эффекта не дают. Избирательное растворение возвращаемой прекращает передачу повреждения после восстановления исходных концентраций . Добавление новых центров вновь запускает цикл после отмены вмешательства. Зависимость от сохраняется при подавлении деления клеток; при сохранённой одно устранение устойчивого выключения не обеспечивает.

Why this is not the mainstream account

The engine is asked to say what its hypothesis would overturn and what would surprise a specialist. This is its answer.

Empirical anchor

В экспериментальной работе Li и соавторов через запускал с участием . Это устанавливает парадоксальную связь гибели и роста, необходимую предлагаемому циклу, но не доказывает его патологическое замыкание при старении. [Первичное исследование ](https://pmc.ncbi.nlm.nih.gov/articles/PMC2905599/).

Subfield revised

Биология стареющих тканей. Пересмотра потребовал бы учебный раздел «Компенсаторная при восстановлении тканей»: в рассматриваемом режиме именно сохранных клеток оказывается обязательным генератором межорганного повреждения, а её временное торможение ускоряет общее восстановление.

Testable surprise

Краткая сохранной сосудистой ускоряет восстановление кишечника и прекращает повреждение обеих тканей после отмены воздействия, хотя исходная сенесцентная сохраняется.

Why this is not the mainstream account

Адресный поиск выявил известные концепции стресса репликации, и полезного действия . Поэтому сами эти компоненты новыми не объявляются. Обзора, утверждающего, что деление первоначально сохранной является обязательным звеном самоподдерживающегося кишечного и сосудистого повреждения и что его краткая остановка устойчиво восстанавливает обе системы, в выполненном поиске не обнаружено. Исчерпывающее доказательство отсутствия такой публикации получить невозможно; статус HERETICAL остаётся предварительным.

What stands behind it

Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.

This hypothesis states no figure and cites no study, so there is nothing here to trace.

CitationsCites nothingFiguresnone statedPredictionWould tell it apart from at least one rivalTo refuteOnly a bench experiment would settle it

What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.

0 citation handles extracted; 1 Europe PMC search run; 0 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.